|
| 37191704 | Global Variations in Heart Failure Etiology, Management, and Outcomes. | JAMA | 2023 |
| 36349701 | Effects of routine early treatment with PCSK9 inhibitors in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a randomised, double-blind, sham-controlled trial. | EuroIntervention | 2022 |
| 35725542 | Length of initial prescription at hospital discharge and long-term medication adherence for elderly, post-myocardial infarction patients: a population-based interrupted time series study. | BMC Med | 2022 |
| 35570198 | Factors associated with health-related quality of life in heart failure in 23â¿¿000 patients from 40 countries: results of the G-CHF research programme. | Eur J Heart Fail | 2022 |
| 36400089 | Influenza vaccine to reduce adverse vascular events in patients with heart failure: a multinational randomised, double-blind, placebo-controlled trial. | Lancet Glob Health | 2022 |
| 33186492 | Polypill with or without Aspirin in Persons without Cardiovascular Disease. | N Engl J Med | 2021 |
| 33906372 | Health-Related Quality of Life and Mortality in Heart Failure: The Global Congestive Heart Failure Study of 23 000 Patients From 40 Countries. | Circulation | 2021 |
| 35265932 | A machine learning-based clinical decision support algorithm for reducing unnecessary coronary angiograms. | Cardiovasc Digit Health J | 2021 |
| 32679282 | A multinational registry to study the characteristics and outcomes of heart failure patients: The global congestive heart failure (G-CHF) registry. | Am Heart J | 2020 |
| 33778443 | Exploring New Models for Cardiovascular Risk Reduction: The Heart Outcomes Prevention and Evaluation 4 (HOPE 4) Canada Pilot Study. | CJC Open | 2020 |
| 33146624 | Length of Initial Prescription at Hospital Discharge and Long-Term Medication Adherence for Elderly, Post-Myocardial Infarction Patients: Protocol for an Interrupted Time Series Study. | JMIR Res Protoc | 2020 |
| 32738949 | Cardiovascular risk in hypertension: open questions about HOPE 4 - Authors' reply. | Lancet | 2020 |
| 31488369 | A community-based comprehensive intervention to reduce cardiovascular risk in hypertension (HOPE 4): a cluster-randomised controlled trial. | Lancet | 2019 |
| 29331282 | Development, Testing, and Implementation of a Training Curriculum for Nonphysician Health Workers to Reduce Cardiovascular Disease. | Glob Heart | 2018 |
| 30015069 | Rationale and design of a cluster randomized trial of a multifaceted intervention in people with hypertension: The Heart Outcomes Prevention and Evaluation 4 (HOPE-4) Study. | Am Heart J | 2018 |
| 27886793 | Innovative Approaches to Hypertension Control in Low- and Middle-Income Countries. | Cardiol Clin | 2017 |
| 28298233 | Developing consensus measures for global programs: lessons from the Global Alliance for Chronic Diseases Hypertension research program. | Global Health | 2017 |
| 28760215 | Interventions Supporting Long-term Adherence aNd Decreasing cardiovascular events (ISLAND): Pragmatic randomized trial protocol. | Am Heart J | 2017 |
| 27538505 | Could patents interfere with the development of a cardiovascular polypill? | J Transl Med | 2016 |
| 25909595 | Patients' knowledge, attitudes, behaviour and health care experiences on the prevention, detection, management and control of hypertension in Colombia: a qualitative study. | PLoS One | 2015 |
| 26135302 | Understanding the modifiable health systems barriers to hypertension management in Malaysia: a multi-method health systems appraisal approach. | BMC Health Serv Res | 2015 |
| 24288261 | Combination pharmacotherapy to prevent cardiovascular disease: present status and challenges. | Eur Heart J | 2014 |
| 23529576 | Combination therapy to prevent cardiovascular disease: slow progress. | JAMA | 2013 |
| 23989317 | Polypill for cardiovascular disease prevention--reply. | JAMA | 2013 |
| 21332987 | Canadian-led capacity-building in biostatistics and methodology in cardiovascular and diabetes trials: the CANNeCTIN Biostatistics and Methodological Innovation Working Group. | Trials | 2011 |
| 20847960 | Canadian Network and Centre for Trials Internationally (CANNeCTIN): a national network for Canadian-led trials in cardiovascular diseases and diabetes mellitus. | Can J Cardiol | 2010 |
| 17456201 | Pretransplant HLA antibodies are associated with reduced graft survival after clinical islet transplantation. | Am J Transplant | 2007 |
| 15665744 | The portal immunosuppressive storm: relevance to islet transplantation? | Ther Drug Monit | 2005 |
| 10660582 | Inhibition of protein phosphatase-1 by clavosines A and B. Novel members of the calyculin family of toxins. | J Biol Chem | 2000 |
| 9114985 | Evidence for a covalently bound form of microcystin-LR in salmon liver and Dungeness crab larvae. | Chem Res Toxicol | 1997 |
| 8960363 | Molecular mechanisms underlying he interaction of motuporin and microcystins with type-1 and type-2A protein phosphatases. | Biochem Cell Biol | 1996 |
| 8146867 | Identification and characterization of hydrophobic microcystins in Canadian freshwater cyanobacteria. | Toxicon | 1993 |
| 1322574 | Factors affecting the toxicity of dioxin-like toxicants: a molecular approach to risk assessment of dioxins. | Toxicol Lett | 1992 |
| 1851747 | Characterization of an inducible aryl hydrocarbon receptor-like protein in rat liver. | J Biol Chem | 1991 |